Michael Charles Riddell

Title: Michael Charles Riddell: Innovator in Diabetes Management

Introduction

Michael Charles Riddell is a notable inventor based in Toronto, Canada. He has made significant contributions to the field of diabetes management through his innovative approaches to insulin dosing guidance. His work focuses on enhancing the quality of life for diabetic patients by providing tailored exercise recommendations.

Latest Patents

Riddell holds a patent for "Methods and apparatus for insulin dosing guidance and decision support for diabetic patient exercise." This patent describes computerized methods and apparatus that assist diabetic patients in managing their insulin dosing while exercising. The techniques outlined in the patent can recommend specific exercises and suggest adjustments to a diabetes treatment plan based on the patient's planned activities. Furthermore, the system customizes an exercise planning tool that considers user preferences and physiological data, ensuring a personalized approach to diabetes management. He has 1 patent to his name.

Career Highlights

Michael Charles Riddell is associated with Eli Lilly and Company, a leading global pharmaceutical company. His work at Eli Lilly focuses on developing innovative solutions for diabetes care, contributing to the advancement of medical technology in this critical area.

Collaborations

Riddell has collaborated with notable colleagues, including Michelle Lynne Katz and Howard Allan Wolpert. These partnerships have fostered a collaborative environment that enhances the development of effective diabetes management solutions.

Conclusion

Michael Charles Riddell's contributions to diabetes management through his innovative patent demonstrate his commitment to improving the lives of diabetic patients. His work exemplifies the intersection of technology and healthcare, paving the way for future advancements in the field.